end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesAndOtherLiabilities,AccruedProfessionalFeesCurrent,AccruedRoyaltiesCurrentAndNoncurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfDebtDiscountPremium,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,AreaOfLand,AssetImpairmentCharges,Assets,AssetsCurrent,AssetsFairValueDisclosure,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,AvailableForSaleSecuritiesDebtSecurities,AvailableForSaleSecuritiesDebtSecuritiesCurrent,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ConversionOfStockAmountConverted1,DeferredIncomeTaxLiabilities,DeferredRentCreditNoncurrent,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DepreciationDepletionAndAmortization,DerivativeLiabilities,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,EmployeeRelatedLiabilitiesCurrent,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpenseOther,InterestIncomeOther,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsDueThereafter,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherNonoperatingIncomeExpense,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromIssuanceOfLongTermDebt,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ReclassificationsOfTemporaryToPermanentEquity,RepaymentsOfDebt,ResearchAndDevelopmentExpense,RestrictedCash,RestrictedCashCurrent,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,ValuationAllowanceDeferredTaxAssetChangeInAmount,VariableLeaseCost,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,DeferredTaxAssetsOther,DeferredTaxAssetsPropertyPlantAndEquipment,DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense,DeferredTaxLiabilitiesLeasingArrangements,MarketableSecuritiesGainLoss,OtherOperatingIncomeExpenseNet,PreferredStockValue,ShortTermLeaseCost
2020-09-30,2020-11-05,10-Q,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,1488000.0,3190000.0,458000.0,,778000.0,,417374000.0,2235000.0,2235000.0,,,,,381472000.0,379840000.0,,,,,,,,,379606000.0,,379606000.0,,0.0001,200000000.0,45445115.0,45004247.0,5000.0,-13920000.0,,,13000.0,,,,,,,,,,,200000.0,,-2.01,,,,,,1318000.0,3841000.0,,,,130000.0,,,997000.0,,800000.0,,,,,197000.0,,14627000.0,381472000.0,4678000.0,9936000.0,,,,-13920000.0,,13520000.0,-13520000.0,,200000.0,,,,,,,,,,,,,,537000.0,191000.0,,-400000.0,,,0.0001,10000000.0,234000.0,,,,,,,2219000.0,1441000.0,,,9679000.0,,,,-50534000.0,,,,,82768.0,0.97,,,,,84984000.0,6337779.0,6.78,84984000.0,6337779.0,6.78,,,,1591000.0,366845000.0,,246411000.0,24000.0,,,,6920008.0,,,,,,,,
2020-12-31,2021-03-04,10-K,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,3440000.0,7527000.0,325000.0,0.0,995000.0,-27000.0,421572000.0,6591000.0,6591000.0,64000.0,7195273.0,,0.0,353334000.0,349087000.0,,,27000.0,44489000.0,28623000.0,52770000.0,44462000.0,,300852000.0,303153000.0,303153000.0,288521000.0,0.0001,200000000.0,45446903.0,45076574.0,5000.0,-59464000.0,162215000.0,43000.0,,,21942000.0,0.0,43000.0,18858000.0,1155000.0,1349000.0,580000.0,21899000.0,43000.0,700000.0,,-4.13,0.0,0.21,-0.27,0.05,-0.01,2105000.0,13447000.0,8567000.0,,3455000.0,396000.0,56000.0,,41728000.0,21672000.0,800000.0,5029000.0,4883000.0,4741000.0,4603000.0,,,10967000.0,353334000.0,10967000.0,,380690000.0,-45661000.0,-46508000.0,-59437000.0,1.0,58647000.0,-58647000.0,,800000.0,,0.0,0.0,,0.0,41728000.0,3452000.0,4993000.0,4847000.0,4706000.0,22930000.0,800000.0,,,,-27000.0,-790000.0,44500000.0,1161000.0,0.0001,10000000.0,3773000.0,246388000.0,134786000.0,9936000.0,0.0,30000.0,-59437000.0,2941000.0,1946000.0,,10000000.0,45200000.0,2300000.0,0.0,2301000.0,-79183000.0,6591000.0,0.75,0.0167,0.0031,447925.0,4.74,200000.0,110484.0,6252967.0,4.5,90112000.0,6421589.0,6.97,90112000.0,6421589.0,6.97,0.93,1.04,7.13,7282000.0,342367000.0,32197.0,246388000.0,30000.0,0.0,16292000.0,,14395955.0,0.0,0.0,0.0,0.0,,,0.0,
2021-03-31,2021-05-06,10-Q,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,5760000.0,7094000.0,131000.0,,1233000.0,-68000.0,582473000.0,3652000.0,3652000.0,,7560471.0,68187.0,,491710000.0,487068000.0,361930000.0,10000.0,78000.0,172204000.0,119510000.0,172136000.0,172136000.0,59000.0,310949000.0,313635000.0,313635000.0,10482000.0,0.0001,200000000.0,51458066.0,51158276.0,6000.0,-25009000.0,,,,,,,,,,,,,,238000.0,,-0.5,,,,,,779000.0,6509000.0,1869000.0,,-331000.0,,166000.0,304000.0,603000.0,,,,,,,603000.0,7000.0,13450000.0,491710000.0,,,157250000.0,-128375000.0,-18393000.0,-24968000.0,1.0,25134000.0,-25134000.0,190000.0,200000.0,596000.0,,,197000.0,562000.0,,,,,,,,0.0325,,,-41000.0,166000.0,132186000.0,9000.0,0.0001,10000000.0,3983000.0,157237000.0,,,,13000.0,-24968000.0,3010000.0,1777000.0,,,18625000.0,2700000.0,383000.0,2303000.0,-104151000.0,3652000.0,0.74,0.0113,0.0088,822408.0,5.34,,,361000.0,11.44,59244000.0,6771426.0,7.55,59244000.0,6771426.0,7.55,1.2,,17.7,8810000.0,478260000.0,11163.0,157237000.0,13000.0,,,114000.0,49472497.0,,,,,,,,
2021-06-30,2021-08-05,10-Q,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,5649000.0,8499000.0,203000.0,,1483000.0,-41000.0,586737000.0,4239000.0,4239000.0,,,68187.0,,467147000.0,461297000.0,,11000.0,52000.0,177245000.0,140960000.0,177204000.0,177204000.0,,258385000.0,261076000.0,261076000.0,,0.0001,200000000.0,51441908.0,51232341.0,6000.0,-29928000.0,,,,,,,,,,,,,,200000.0,,-0.58,,,,,,1591000.0,6293000.0,,,,,210000.0,320000.0,406000.0,,,,,,,406000.0,3000.0,14551000.0,467147000.0,,,,,,-29955000.0,,30165000.0,-30165000.0,189000.0,200000.0,403000.0,,,,376000.0,,,,,,,,0.0325,,,27000.0,210000.0,,,0.0001,10000000.0,25708000.0,,,,,,,4072000.0,2589000.0,,,23872000.0,2700000.0,383000.0,2308000.0,-134106000.0,,,,,1186660.0,5.59,,,,,94783000.0,7160650.0,8.2,87112000.0,6767389.0,8.17,,,,18804000.0,452596000.0,,,25000.0,,,131000.0,51216254.0,,,,,,,,
2021-09-30,2021-11-04,10-Q,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,7088000.0,11674000.0,136000.0,,1742000.0,-34000.0,590832000.0,3638000.0,3638000.0,,,,,466878000.0,424655000.0,,16000.0,50000.0,178515000.0,131877000.0,178481000.0,178481000.0,,229042000.0,231733000.0,231733000.0,,0.0001,200000000.0,51607908.0,51483643.0,6000.0,-42575000.0,,,,,,,,,,,,,,300000.0,,-0.83,,,,,,2693000.0,6256000.0,,,,,184000.0,324000.0,43319000.0,,3452000.0,,4993000.0,4847000.0,4706000.0,2391000.0,9319000.0,52762000.0,466878000.0,23351000.0,,,,,-42582000.0,,42766000.0,-42766000.0,189000.0,200000.0,34000000.0,4589000.0,29411000.0,,36927000.0,,,,,,,,0.0579,,,7000.0,184000.0,,,0.0001,10000000.0,17132000.0,,,,,,,4730000.0,2988000.0,,,36510000.0,2700000.0,383000.0,2308000.0,-176688000.0,,,,,1567826.0,5.91,,,,,60678000.0,7325672.0,8.73,57499000.0,6932411.0,8.73,,,,16944000.0,414116000.0,,,457000.0,,,135000.0,51320940.0,,,,,,,,
2021-12-31,2022-03-10,10-K,"Dyne Therapeutics, Inc.",DYN,CIK0001818794,USD,4031000.0,20799000.0,184000.0,,1983000.0,-269000.0,596934000.0,17542000.0,17542000.0,,9062875.0,,0.0,425663000.0,382392000.0,,3000.0,272000.0,176015000.0,140919000.0,175746000.0,175746000.0,202000.0,200825000.0,203519000.0,203519000.0,-99634000.0,0.0001,200000000.0,51607522.0,51569381.0,6000.0,-149533000.0,,9912000.0,,,73458000.0,0.0,9912000.0,51500000.0,4799000.0,2333000.0,5205000.0,63546000.0,0.0,1088000.0,,-2.93,0.0,0.21,-0.27,0.05,-0.02,5097000.0,28717000.0,13702000.0,,1506000.0,,742000.0,2699000.0,41484000.0,17787000.0,4008000.0,5143000.0,4993000.0,4847000.0,4706000.0,,8848000.0,57466000.0,425663000.0,28723000.0,,157821000.0,-137892000.0,-119563000.0,-149291000.0,1.0,150025000.0,-150025000.0,2126000.0,2100000.0,32636000.0,3893000.0,28743000.0,800000.0,36282000.0,,,,,,,,0.058,,,-242000.0,734000.0,236721000.0,3618000.0,0.0001,10000000.0,5821000.0,,,,4437000.0,584000.0,-149291000.0,6661000.0,4678000.0,,,121308000.0,2700000.0,383000.0,2311000.0,-228474000.0,17542000.0,0.74,0.0134,0.0082,1872885.0,6.13,1900000.0,547156.0,2240816.0,10.23,36946000.0,7967750.0,9.35,36946000.0,7967750.0,9.35,3.96,9.44,15.84,13227000.0,368197000.0,147499.0,157237000.0,584000.0,0.0,41647000.0,573000.0,50895044.0,8916000.0,705000.0,0.0,9912000.0,8000.0,-8000.0,0.0,0.0
